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Developing interventions that aim to promote mental health has increasingly been 
recognised as a global priority (World Health Organis tion, 2015). In the UK and 
internationally, this agenda has been reflected in the burgeoning number of public policy, 
legislation, programmes and interventions which aimto enhance the mental health of 
individuals and their communities (e.g. Department of Health, 2014, New Economics 
Foundation, 2011; Office for National Statistics, 2019).    
 Conceptually, mental health promotion broadens the focus of researchers’ and 
clinicians’ attention towards improving indicators of well-being and health, in addition to 
more narrowly focused efforts to alleviate psychological distress or ‘illness’. The ‘dual-factor 
model of mental health’ (Westerhof & Keyes, 2010) proposes that mental health and mental 
illness exist on distinct, yet related, dimensions. A growing body of research evidence 
attests to the possibility that positive mental health (i.e. elevated subjective wellbeing; 
SWB) ‘buffers’ against mental and physical illness (Grant, Guille, & Sen, 2013; Keyes, 
Dhingra, & Simoes, 2010; Steptoe, Docray & Wardle, 2009). As such, SWB has been 
highlighted as an important outcome for clinicians d researchers involved in delivery and 
evaluating psychological interventions respectively (Diener, Diener, & Tamir, 2004; 
Trompetter, De Kleine, &Bohlmeijer, 2017; White, Imperiale, & Perera, 2016).  
 SWB has been defined broadly as “a person’s cognitive and affective evaluations of 
his or her life” (Diener, Oishi, & Lucas, 2002, pp.63), and has been proposed to consist of 
hedonic and eudaimonic aspects (Keyes, Scmotkin & Ryff, 2002; Waterman, 1993). Hedonia 
relates to satisfaction with life, and an emotional equilibrium between positive affect (e.g. 
happiness) and negative affect (Diener, Emmons, Larsen, & Griffin, 1985; Deiner, Suh, 
Lucas, & Smith, 1999; Larsen & Prizmic, 2008). Eudaimonia concerns optimal, 
psychological functioning and fulfilment of one’s own potential (i.e. “self-acceptance”, 
“environmental mastery”, “positive social relationships”, and “purpose in life”) (Ryff & 
Keyes, 1995, pp.720).          
 There exists a wealth of validated, self-report wellbeing measures for which 
underlying conceptualizations may be divided into hedonic and eudemonic traditions (for a 
comprehensive review of measures see Cooke, Melchert, & Connor, 2016). Increasingly, 
measures have been developed to capture both of these aspects of wellbeing. For example, 
Keyes (2002) argues that emotional (i.e. hedonic), psychological and social (both eudemonic) 
components constitute the core aspects of wellbeing. Furthermore, it is suggested that 
individuals may be classified as “flourishing”, “languishing”, or in “moderate mental health” 
depending on their levels of SWB as assessed by the Mental Health Continuum (MHC-Short-
Form/Long Form; Keyes, 2002). This theoretical understanding of wellbeing aligns closely 
with the World Health Organisation’s (WHO) definition of mental health: “a state 
of wellbeing in which the individual realizes his or her own abilities, can cope with the 
normal stresses of life, can work productively and fruitfully, and is able to make a 
contribution to his or her community” (2001, p.1).      
     Acceptance and commitment therapy (ACT) is a 
transdiagnostic intervention, which focuses on personal growth, and the cultivation of 
wellbeing through enhanced value-based living (Harris, 2011; Hayes, 2004). Underpinned by 
functional contextualism, ACT moves away from reductionist approaches to therapy that aim 
to correct the content of “dysfunctional” or “pathological” cognitions and behaviours; instead 
focusing on the context in which psychological and behavioural events occur. In ACT, 
psychological suffering is considered to be caused by a lack of “psychological flexibility”, 











contains without defence, and, persisting in or changing behaviour in the pursuit of goals and 
values” (Bond et al., 2011, pp. 678). In order to enhance psychological flexibility, ACT 
draws on six therapeutic processes: acceptance (embracing internal experiences without 
altering their form or frequency); cognitive defusion (achieving psychological distance from 
internal experiences); being present (ongoing, non-judgemental contact with psychological 
and environmental events as they occur); self-as-context (observing or noticing ones’ inner/ 
outer world, and flexible perspective taking); values (choosing valued life directions); and 
committed action (acting in service of one’s chosen values).    
    Whilst ACT does not view symptom reduction itself as a primary 
goal, this can be a fortuitous by-product of enhanced psychological flexibility. Further, ACT 
takes a non-pathologising stance towards human distress, emphasising instead that distress is 
an inherent aspect of the ‘human condition’ (Ramsey & Wade, 2015).    
  Reflecting an evidence-based practice focus on measuring the efficacy of 
interventions in terms of symptom reduction, a large proportion of ACT studies have focused 
on “disorders” and condition-specific outcomes (e.g. Beilby, Bymes, & Yaruss, 2012; 
Bohlmeijer, Fledderus, & Rokx, 2011; Lappalainen et al., 2014). A number of systematic 
reviews and meta-analysis have been conducted (Powers, Vording, & Emmelkamp, 2009; 
Swain, Hancock, Hainsworth, & Bowman, 2013; A-Tjak et al., 2015). Research has 
demonstrated ACT’s efficacy in relation to anxiety and depression (e.g. Forman, Herbert, 
Moitra, Yeomans, Geller, 2007) and a range of mental he lth difficulties (e.g. Gratz & 
Gunderson, 2006; Hayes, 2004) and physical health conditions (e.g. Dahl, Wilson, & Nilsson, 
2004). Yet there have been recent calls for research efforts to focus on transdiagnostic 
outcomes such as SWB (Fledderus, Bohlmeijer, Smit & Westerhof, 2010; French, Golijani-
Moghaddam, & Schröder, 2017; Trompetter, Bohlmeijer, Lamers, & Schreurs, 2016).  
 In the current review, the authors sought to address an important gap within the 
literature base, by synthesising and critically appr ising the research findings of randomised 
controlled trials (RCTs) of face-to-face and guided ACT interventions (i.e. an ACT 
intervention where the participant had at least mini al contact with a practitioner linked to 
the intervention) that have assessed SWB in adults. Face-to-face and guided interventions 
were chosen as the focus of this review, as they have been shown to be superior to unguided 
interventions within the literature (Anderson & Titov, 2014; French et al., 2017; Richards & 
Richardson, 2012).The current study aimed to evaluate the methodological rigor of RCTs of 
ACT interventions; the ranges of standardised SWB measures being used; and the reported 
efficacy of ACT (versus control groups) for bringin about changes in SWB. Specifically, the 
current review, and meta-analysis aimed to address the following questions:  
 
1. What is the range of SWB measures used as outcome measures in ACT RCT 
intervention studies? 
 
2. What is the efficacy of ACT interventions (compared to control groups) for bringing 
about changes in subjective well-being?  



















Pre-registration of the systematic review protocol 
 
The protocol for this review was registered with the International Prospective Register 




Following initial scoping searches, four electronic databases (Medline, PsycINFO, 
Scopus and Web of Science) were searched for relevant literature from inception to July 
2018. Search terms were adapted from a previous, published review exploring SWB in a 
clinical sample (Schrank et al., 2013). An information specialist with expertise in 
bibliographic databases was consulted, and helped in devising the final search strategy. As 
ACT is a transdiagnostic approach, and in keeping with the exclusion criteria for this review, 
no ‘disorder’ or condition-specific keywords were included. The following search terms were 
used: 
 
(“well-being’” OR “wellbeing” OR “wellness” OR “hapiness” OR “happy” OR 
“thriv*” OR “flourish*”O R “pleasure” OR “joy” OR “life ADJ2 satisfaction” OR 
“satisfaction ADJ2 with life” OR “strength*”OR “blessing*” OR “virtue*” OR “good ADJ2 
life” OR “fulfilment” OR “eudaimonia” OR “eudaemonia” OR “hedonism”) AND 
(“randomi*ed controlled trial” OR “controlled clinical trial” OR “groups” OR “trial” OR 
“treatment as usual” OR “TAU” OR “control*” OR “randomi*d” OR “waitlist*” OR 
“placebo”) AND ("Acceptance and Commitment Therapy” OR “ACT ADJ3 treatment* OR 
“ACT ADJ3 intervention*” OR “ACT ADJ3 therap*).  
 
Search terms were adjusted for each database, includ g the use of MeSH terms and 
Cochrane filters (Higgins & Green, 2011) as required. English language limiters were applied 
in three databases (Medline, Scopus, and Web of Science) and in Medline results were 
restricted to human participants.  Appendix A details  full search conducted in Medline.  
Additionally, all reference lists of the included studies, as well as recently published, 
systematic reviews relevant to the review topic were searched (e.g. Brown, Glendenning, 
Hoon, & John, 2016; French et al., 2017). Finally, experts in the field were contacted by 




Studies were included in the current review provided they met the following inclusion 
criteria: a) were RCTs of interventions described by authors as “Acceptance and 
Commitment Therapy” or “ACT”; b) were delivered in either group, one-to-one format, or 
were a guided/supported form of ACT self-help intervention (i.e. an ACT intervention where 
the participant had at least minimal contact with a pr ctitioner linked to the intervention); c) 











control); d) included a standardised measure of SWB1 (see Cooke et al., 2016 and Appendix 
B) pre- and post-intervention as either a primary or secondary outcome; e) reported data from 
adult participants (18 years or older); f) were published in a peer-reviewed journal. Reviews, 
case studies, protocols, discussion articles, and other study designs were excluded. Any 
reanalysis of data from previously published studies, and papers not published in the English 
language were also excluded from the review. Lastly, ACT interventions combined with 
another form of intervention (e.g. ACT plus behavioural activation), or unguided/ 
unsupported ACT interventions were excluded.  
Interventions requiring at least a minimal contact wi h a person supporting the 
delivery of the intervention were chosen as previous reviews have focused exclusively on 
unguided self-help or web-based interventions (e.g. Brown, Glendenning, Hoon, & John, A, 
2016). Additionally the studies included in this review focused on adult participants, due to 
marked differences in how interventions are designed and delivered according to whether 
those receiving the intervention are children/adolescents versus adults. ACT studies that 
combined other interventions (e.g. including ACT plus behavioural activation) were 
excluded. Although there may be some overlap in the rationale for ACT and behavioural 
activation, there are also some important differences. Indeed, Kanter et al. (2006) stated that 
‘the two treatments differ dramatically and may in fact present opposing conceptualizations’ 
(P106). 
Following the searches, and removal of all duplicate records, titles and abstracts were 
simultaneously screened to assess their eligibility for inclusion. To ensure systematic article 
selection, a screening tool was used (Appendix C). Full papers of potentially relevant articles 
were then assessed. Screening was undertaken at both stages independently by X.X and an 
assistant psychologist (X.X). Agreement at both stages was high (stage 1: k=.87, stage 2: 
k=.80). Any differences in judgement were discussed an  resolved. A third reviewer was 
available to resolve any discrepancies; however this was not necessary as consensus was 
reached in all instances.  
Risk of bias 
 
 The Cochrane Risk of Bias Tool (RoB; Higgins & Green, 2011) was used to evaluate 
risk of bias. The use of this tool is endorsed by the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines (Liberati et al., 2009), and it is widely 
used in the evaluation of methodological quality of RCTs. The tool includes six domains: (1) 
“random sequence generation”, (2) “allocation concealm nt”, (3) “blinding of participants 
and personnel”, (4) “blinding of outcome assessment”, (5) “incomplete outcome data”, (6) 
and “selective outcome reporting”. In line with recommendations by Munder & Barth (2017) 
when using RoB in the context of psychological intervention research, a seventh domain was 
also considered (7) deviations from intended interventions. Emphasized in the revised RoB 
(2.0) presently at the draft stage (Higgins et al., 2016) this domain allowed consideration of 
treatment adherence, and integrity. Each domain was assessed as being either ‘low’, ‘high’ or 
‘unclear’ in terms of risk of bias. Assessments were undertaken by X.X and X.X. Consensus 
was high and disagreements were resolved though discussion, without the need for arbitration 
from a third reviewer. 
                                                          
1 Note: Where a SWB measure was not listed by Cooke, Melchert, & Conner (2016) (Appendix B) the authors 
considered the measure against criteria set out by Cooke et al. (2016). One study (Grégoire, Lachance, Bouffard, 
























































Records identified through database 
searches  
 
PsychINFO (n=264)                 
Medline (n=109)                        
Web of Science (n=267)          
Scopus (n=280)                                             
(Total n=921) 
Records identified 
through other sources 
(n =1) 






Full-text articles assessed for 
eligibility 
(n = 63) 
Studies included in the synthesis 
(n = 11) 
Full-text articles 
excluded (n =52) 
No SWB measure: n=25     
Not an RCT:  n=9 
Secondary analysis: n=3                     
Not in English: n=2       
Combined therapy: n=4  
Under 18 years: n=1            
Dissertation: n=4       


















































Data extraction and analysis 
 
Sample demographics, study characteristics and outcomes were extracted using a data 
extraction form devised specifically for this systematic review. This form was checked 
independently for accuracy and completeness by X.X. Disagreements were again resolved 
through discussion. Details of all outcome measures tili ed in each study were collated yet 
results were only extracted for measures of SWB in line with the aims of this review (see 
Table 3). A further supplementary (Table 4) present further details of the primary outcome 
findings alongside SWB findings. The Centre for Epidemiologic Studies Depression Scale 
(CES-D), and the Patient Health Questionnaire-9 (PHQ-9) appeared to be the most 
commonly used primary outcome measure other than SWB measures. Of the seven studies 
that included a primary outcome measure (e.g. stress, depression, anxiety, pain interference) 
other than/ or additional to SWB measures, all repot d significant reductions of these 
symptoms in the ACT group as compared to an active or wait-list comparator. 
Heterogeneity in participant characteristics, diversity in intervention formats observed 
and particularly in the SWB outcome measures used. Therefore, a meta-analysis pooling the 
SWB outcomes of all included studies was deemed inappropriate. Instead, meta-analyses 
were conducted separately for each SWB measure post-treatment (MHC-SF score, 
Psychological Wellbeing (PWB) score, Satisfaction with Life Survey Score (SWLS) score, 
Well-Being Manifestations Measure Scale (WBMMS) score and Warwick–Edinburgh Mental 
Well-being Scale (WEMWBS) score).   
Two studies reported results for MHC-SF domains (emotional, social and 
psychological wellbeing) separately and three studies reported results for MHC-SF total 
score. To facilitate meta-analysis, MHC-SF domain summary scores (i.e. means and standard 
deviations for intervention and control groups) were combined to provide MHC-SF total 
summary scores according to the scoring manual of the MHC-SF and guidance for combining 
means and standard deviations within Chapter 6.5.2.10 of the Cochrane Handbook (Higgins 
& Deeks, 2019). Other SWB measures were all reported as total score. 
One study included two ACT intervention groups (with extensive e-mail support 
[ACT-E] and with minimal e-mail support [ACT-M]). To allow comparisons for both of the 
ACT intervention groups to the waiting list control group to be included in meta-analysis 
without multiple counting of the control group, the number of participants in the control 
group was divided by two when calculating the mean difference and associated standard error 
for the comparisons in this study. 
To allow for visual comparison of ACT compared to control across the SWB outcome 
measures, meta-analyses was conducted using the effect measure standardised mean 
difference (SMD) and associated 95% confidence interval (CI) and presented within a single 
forest plot. The SMD is a standardised measure usedin meta-analysis when included studies 
assess the same outcome but measure it in a variety of ways. The SMD is a similar measure 
to Cohen’s d and can be interpreted as follows: 0.2 represents a small effect, 0.5 a moderate 
effect and 0.8 a large effect (Cohen, 1988).  
Meta-analyses were conducted via the generic inverse variance method of meta-
analysis in Stata version 14 statistical software (D eks, Higgins & Altman, 2019). Due to 
observed heterogeneity in participant characteristics, intervention formats and control 











studies was assessed by visual inspection of the meta-analysis forest plot and formally 
according to the I2 statistic (the percentage of variability between trials that is due to 
statistical heterogeneity). 
Most of the studies also reported SWB scores at a post-intervention follow-up time in 
the ACT intervention groups. However, follow-up times were variable, ranging from 4 weeks 
to 52 weeks and scores were often not reported at follow-up times within the control groups. 
Therefore, it was deemed that data were too limited an  variable for a meaningful meta-
analysis of SWB outcomes at follow-up. 
For other outcomes, substantial heterogeneity in participant population and outcome 




Figure 1 illustrates the PRISMA flow from searches to included articles as 
recommended by PRISMA guidelines. The searches identified 921 records, of which 11 
studies met full criteria and are included in the current review.   
Sample Characteristics and Demographics 
 
 Overall, 1108 participants took were recruited to the included studies. Of the ten 
studies that reported gender numbers 34% (n=357 out of 1048 participants) were male. 
Azkhosh, Farhoudianm, Saadati, Shoaee, and Lashani (2016) did not report information on 
gender. One study did not report the specific ages of participants (Bayati, Abbasi, Bashiri, 
Dehghan, & Yazdanbakhsh, 2017). The median for the mean age of participants from the 
remaining ten studies that did report this information was 44 years (Interquartile range = 27-
50). Studies were from a range of countries including: four from the Netherlands (Fledderus 
et al., 2010; Fledderus, Bohlmeijer, Pieterse, & Schreurs, 2012; Pots et al., 2016; Trompetter, 
Bohlmeijer, Veehof, & Schreurs, 2014); one from theUK (Majundar & Morris, 2018); one 
from Sweden (Thorsell et al., 2011); one from Canad (Grégoire, Lachance, Bouffard, & 
Dionne, 2018); two from Iran (Azkhosh et al., 2016; Bayati et al., 2017); one from Finland 
(Räsänen, Lappalainen, Muotka, Tolvanen, & Lappalainen, 2016); and one from India 
(Lundgren, Dahl, Yardi, & Melin, 2008). Of the studies that recruited from clinical settings, a 
range of physical and mental health difficulties were targeted including participants with: an 
addiction to opiates (Azkhosh et al., 2016); multiple sclerosis (Bayati et al., 2017); chronic 
pain (Thorsell et al., 2011); a previous history of stroke/s (Majundar & Morris, 2018); drug-
refractory epilepsy (Lundgren et al., 2008) and mild-moderate distress (Fledderus et al., 
2010). Of those studies that recruited from the general population (non-clinical settings) two 
studies included participants with symptoms of depression (Fledderus et al., 2012; Pots et al., 
2016); one included participants with self-reported distress including anxiety, stress, low 
mood and/or anxiety (Ransanen et al., 2016); one study included participants with chronic 
pain (Trompetter et al., 2014) and one study was aimed at mental health promotion (Grégoire 
et al., 2018). Table 2 illustrates participants’ characteristics across the included studies. 
Results of risk of bias 
 A risk of bias graph (Figure 2), as well as the risk of bias assessment is presented 
(Figure 3). In-line with recommendations from the Cntre for Review and Dissemination 











study. Common methodological problems highlighted across the included trials related to 
allocation concealment, incomplete data, and small sample sizes.  
Nine of the included studies reported adequate methods for “random sequence 
generation” such as computer generated random sequences and drawing of lots (Fledderus et 
al., 2010;  Fledderus et al., 2012; Grégoire et al., 2018; Lundgren et al., 2008; Majundar & 
Morris, 2018; Pots et al., 2016; Ransanen et al., 2016; Thorsell et al., 2011; Trompetter et al., 
2014). These studies were therefore deemed low risk of selection bias. In two studies, the 
authors presented insufficient information to asses ri k of selection bias (Azhosh et al., 
2016; Bayati et al., 2017). Only four studies were considered to be at low risk of selection 
bias (“allocation concealment”) as allocation in these RCTs was undertaken by parties 
external to the research team (Fledderus et al., 2010; Grégoire et al., 2018; Majundar & 
Morris, 2018; Ransanen et al., 2016). All other studies were deemed an unclear risk.  
With regards to “blinding of participants and personnel”, a high risk of performance 
bias was found across all studies. This is reflectiv  of psychotherapy research in general, as 
blinding of participants and therapists in interventio  trials of this nature is unfeasible 
(Munder & Barth, 2017). As all included studies reported self-report measures, participants 
were considered to be equivalent to “blind clinical observers” as is common practice in 
systematic reviews of therapy trials (Munder & Barth, 2017, pp. 6) meaning that detection 
bias was assessed as ‘low risk’ in all included stuies.  
 The majority of studies assessed outcomes over three time-points; pre-and-post 
intervention and follow-up (ranging from 6 weeks to 12 months) (Azhosh et al., 2016; Bayati 
et al., 2017; Fledderus et al., 2010; Fledderus et al., 2012; Majundar & Morris, 2018; Rasanen 
et al., 2016; Trompetter et al., 2014). Three studies included four assessment time-points; pre 
and post intervention and follow-up assessments at 6 and 12 months (Lundgren et al., 2008; 
Pots et al., 2016; Thorsell et al., 2011). One remaining study included only pre-and-post 
assessments (Grégoire et al., 2018).  
When handling incomplete outcome data, six studies used intention-to-treat analysis, 
and were deemed low risk of attrition bias (Fledderus et al., 2010; Fledderus et al., 2012; Pots 
et al., 2016; Ransanen et al., 2016; Thorsell et al., 2011; Trompetter et al., 2014). Of the 
remaining five studies, one had no attrition and was also classed as low risk (Lundgren et al., 
2008); two provided insufficient information on attrition, the reasons for drop-out or how 
missing data was handled and were therefore deemed as an unclear risk (Azhosh et al., 2016; 
Bayati et al., 2017); and two studies used inappropriate simple imputation methods (last 
observation carried forward) when handling missing data and were consequently deemed at 
‘high risk’ of attrition bias (Grégoire et al., 2018; Majundar & Morris., 2018).  
 Two study protocols were available and located, which reported all pre-specified 
outcomes in the published paper, and as such were de med low risk of selection bias (Pots et 
al., 2016; Trompetter et al., 2014).  One study made reference to a protocol, yet on inspection 
did not report all pre-specified outcomes listed in the final paper. This study was therefore 
judged as high risk (Bayati et al., 2017). All other included studies did report all expected 
outcomes that were specified in the aims and hypotheses section of the report, however they 
did not make reference to a published protocol. These studies were deemed ‘unclear risk’.   
 An additional domain “deviations from intended interventions” was also considered 
(Higgins, et al., 2016). As highlighted by Munder and Barth (2017) where blinding patients 
and therapists are not possible (as with all therapeutic trials), low risk of bias in this domain 
needs to be ensured by providing sufficient information regarding treatment implementation. 
Of the six studies that included at least one active comparison group, four were judged as low 
risk. These studies provided detailed descriptions of interventions, of which the majority were 
manualised. Supervised therapist training and/or checks for therapy fidelity were 











were also balanced across active groups (Fledderus et al., 2012; Pots et al., 2016; Thorsell et 
al., 2011; Trompetter et al., 2014).  
The remaining two studies were deemed an unclear risk in terms of “deviations from 
intended interventions” due to insufficient information regarding treatment integrity or 
participant adherence. Of the five studies with non-active controls (e.g. WLC) three were 
judged as low risk as detailed descriptions of interventions, therapist training, and fidelity 
measures were provided. Additionally, participant adherence was high (all participants 
completing at least 75% of the intervention) (Grégoire et al., 2018; Majundar & Morris, 
2018; Rasanen et al., 2016). The remaining two studies with non-active controls, were 
deemed an unclear risk (Bayati et al., 2017; Fledderus t al., 2010). 
 Three studies (Pots et al., 2016; Ransanen et al., 2016; & Trompetter et al, 2014) 
demonstrated comparatively low levels of risk of bias overall; reporting low risk in five or 






























































 In-line with criteria of the review all of the studies were RCTs, and included either an 
active comparison (n=2: Lundgren et al., 2008; Thorsell et al., 2011); a non-active control 
(n=5: Bayati et al., 2017; Fledderus et al., 2010; Grego ie et al., 2018; Majumdar & Morris, 
2018; Rasanen et al., 2016) or both (n=4; Azkhosh et al., 2016; Fledderus et al., 2012; Pots et 
al., 2016; Trompetter et al., 2014). Table 3 summarises study characteristics, and findings for 
all included studies.  
Intervention characteristics 
 
 Five studies investigated interventions delivered in a group format (Azkhosh et al., 
2016; Bayati et al., 2017; Fledderus et al., 2010; Gregorie et al., 2018; Majumdar & Morris., 
2018). These studies compared ACT group/s to predominantly non-active control groups, 
with only one study including an active comparison: a Narcotics Anonymous Group (NA; 
Azkhosh et al., 2016). The majority of interventions were manualised, and included detailed 
description of the core ACT processes and techniques covered in sessions (n=4). Only one 
study did not provide details of the ACT interventio  (Azkhosh et al., 2016). Group sessions 
were delivered weekly in all five studies, with each session lasting between 1.5-2.5 hours. 
The duration of these interventions ranged from four t  12 weeks. Group sizes/and or the 
number of groups were not specified in the majority of these studies.  
In three studies, groups were delivered across multiple sites (Fledderus et al., 2010; 
Gregorie et al., 2018; Majumdar & Morris, 2018). Additionally one study included a mixed 
intervention (group and individual sessions) (Lundgren et al., 2008). In this study, a 
manualised ACT intervention was compared to a Yoga intervention. Over a period of five-
weeks, all participants were offered two individual sessions and two group sessions. Booster 
sessions were also delivered at six and twelve months.    
 Five studies included guided, self-help interventio s; of which three were delivered 
via an online website (Pots et al., 2016; Rasanen et al., 2016; Trompetter et al., 2014). Two of 
these studies included an active comparison: an expressive writing (EW) online intervention 
(Pots et al., 2016; Trompetter et al., 2014).  All of these online studies provided detailed 
descriptions of the core ACT processes and techniques covered in the online modules. The 
number of modules completed ranged from 5-9 modules, d livered over the duration of 7-12 
weeks. Weekly email support and feedback, as well as reminder texts were sent to 
participants in these online, guided self-help interventions. Lastly, two studies delivered 
guided, self-help interventions through the provision of self-help books to participants 
(Fledderus et al., 2012; Thorsell et al., 2011). Fledderus et al. (2012) compared two ACT 
interventions: a self-help book with minimal guidance (i.e. standardized emails and positive 
encouragement), to an extensive guidance condition (i.e. personalised email feedback and 
advice), and a waiting list control (WLC). Thorsell t al. (2011) compared participants given 
an ACT self-help book, to an applied relaxation (AR) manual. In both interventions, 
participants received two individual sessions, and weekly telephone guidance and support. 
The duration of these interventions was between 7-9 weeks.  
 The majority of interventions were delivered by clini al psychology trainees/ students 
(n=6), followed by clinical psychologists and other health-care professionals (i.e. care co-
ordinators, assistant psychologists) (n=3). In two studies the profession of those that 















Ten out of the 11 included studies included data on ttrition. Only one study failed to 
report this information (Bayati et al., 2017). In these studies, non-active control groups had a 
mean average of 11% (range=0-42%) attrition at time point 1 (T1; post-intervention), in 
comparison to intervention groups 23% (range= 0-50%). Of those studies that included 
follow-ups (FUP) and associated attrition rates (Fledderus et al., 2010; Fledderus et al., 2012; 
Lundgren et al., 2008; Majumdar & Morris, 2018; Pots e  al., 2016; Rasanen et al., 2016; 
Thorsell et al., 2011; Trompetter et al., 2014) attrition rates at FUP (T2; ranging from 8-52 
weeks) were, as could be expected, higher (overall mean in passive control and intervention 
groups=28%; range=0-56%). Three studies included a second FUP (T3; all at 52 weeks) 
(Lundgren et al., 2008; Pots et al., 2016; Thorsell et al., 2011). In these studies the mean 
attrition rate at this time point (across all groups) was 31% (range= 0-73%). Overall, limited 
information was provided in regards to reasons for attrition in the included studies.  
Standardised Wellbeing Measures 
 
The included studies utilised a number of different, validated measures of SWB. 
Authors did not explicitly state why each measure was chosen. In five of the included studies, 
the Mental Health Continuum-Short-Form (MHC-SF) was u ed. Two studies used the 
Psychological Well-being (PWB) scale. In two studies the Satisfaction with Life Scale 
(SWLS) was utilised. Finally, one study included the Warwick and Edinburgh Mental Well-
being Scale (WEMWBS), and one study used the Well-being Manifestation Scale 
(WBMMS). As noted previously, the decision was made to include the WBMMS in our 
review. Although it was not included as a standardise  measure of wellbeing in the review by 
Cooke et al. (2016), it did meet criteria specified their review of SWB measures. 
Furthermore, there were available details of reliability and validity for this measure (Massé et 






















Table1: Summary of SWB Measures Utilised in the Included Studies 









Three domains: emotional well-being 
(happy, interested in life, satisfied), 




(Fledderus et al., 2010; 
 Fledderus et al., 2012; Pots et al., 
2016; Rasanen et al., 2016; 






Six domains: autonomy, environmental 
mastery, personal growth, positive 




(Azkhosh et al., 2016; Bayati et 
al., 2017) 
 
Satisfaction with Life 
Scale (SWLS) 
 
Uni-dimensional. Five items: designed 
to measure global cognitive judgments 











The six factors or subscales of the 
WBMMS are: control Meaning in Life 
and Psychological Well-Being of self 
and events, happiness, social 
involvement, self-esteem, mental 
balance, and sociability 
n=1 








Uni-dimensional. 14 items: designed to 
measure subjective wellbeing and 
psychological functioning  
 
                     n=1 
(Majumdar & Morris, 2018) 
   
 
 
Additional Outcome Measures 
 
Table 3 illustrates the range of additional measures (n=24) administered in each of the 
included studies. The diversity in these measures reflects the heterogeneity of targeted sample 
populations/characteristics included in the review. The most frequently used measures 
alongside SWB measures included ACT-related process measures such as psychological 
flexibility measures (e.g. the Acceptance and Action Questionnaire; AAQ-II; Bond et al., 
2011)  and measures of clinical symptoms such as anxiety or depression (e.g. Hospital 


















Figure 4: Meta-analysis of Standardised Mean Difference in Wellbeing Scores Post 




SMD=standardised mean difference. can be interpreted as follows: 0.2 represents a small effect, 0.5 a moderate 





Study findings and efficacy of interventions 
 
Results of the meta-analyses  
 
As mentioned previously, meta-analyses were separately for each SWB measure post-
treatment (MHC-SF score, PWB score, SWLS score, WBMMS score and WEMWBS score). 
As previously stated, SMD is a standardised measure used in meta-analysis when included 
studies assess the same outcome (SWB) but measure it in a variety of ways.  As illustrated in 
Figure 4, results in those studies that measured SWB using the MHC-SF, and SWLS show 
consistent, significant small-moderate effect sizes n favour of ACT (MHC-SF subtotal; 











regards to the two studies that utilised the PWB to measure SWB, both showed significant, 
very large effects favouring ACT (PWB subtotal; SMD=1.6 (0.63 to 2.58)). It is important to 
note that in regards to these two studies, there is a h gh level of heterogeneity (I-
squared=62%), and that sample sizes in these studie were small.  The one study that utilised 
the WBMMS (Gregorie et al., 2018) reported a moderate, significant effect in favour of ACT 
(SMD=0.58 (95% CI 0.24 to 0.91). Finally, the one study that measured SWB with the 
WEMWBS scale (Majumdar & Morris, 2018), showed a small, non-significant effect in 
favour of ACT (SMD= 0.15 (95% CI -0.39 to 0.69)).  
It is important to note that the control groups included in the meta-analyses included 
wait-list controls, treatment as usual, and active int rventions (such as methodone and yoga). 
As stated earlier in this paper, it must also be acknowledged that a wide variety of 
populations and clinical conditions have been pooled in the current analysis. Furthermore, 
while ACT was delivered in a group format in five of the included studies and in an 
individual format in six of the included studies (Table 3), the results of this meta-analysis do 
not account for ‘group effects’. Whilst one paper included did report an adjusted result for 
‘group effects’ (Fledderus et al, 2010) this was not i  a format that could be incorporated into 
the analysis.   
 
Results of individual studies that conducted follow-up assessments 
 
Whilst data available for meta-analyses precluded analysis of follow-up (FUP), a 
number of studies included and reported on FUP outcomes. Of the group interventions, 
Fledderus et al. (2010) reported that gains (favouring ACT) were maintained at 20 weeks. 
Majumdar & Morris et al. (2018) reported that at 8 weeks, study gains (favouring ACT) were 
not maintained.  Two guided, online interventions icluded FUPs (T2-3; 26-52 weeks), and 
gains (in favour of ACT) were maintained at these timepoints (Pots et al., 2016, Rasanen et 
al., 2016). Finally, two studies reporting guided, interventions with the provision of self-help 
books and email/individual support included  FUP (Fledderus et al., 2012; Thorsell et al., 


























male) Population  
Clinical or Non-Clinical/ Recruitment 
Azkhosh et al., 2016 Iran 60 27.5 (n/s) (n/s) 
Individuals with an addiction to opiates, no 
symptoms of psychosis 
Clinical sample, recruited from drug 
rehabilitation centres   
Bayati et al., 2017 Iran 30 n/s (18-55) 0  
Females with a diagnosis of multiple-sclerosis, 
no other physical, or mental health diagnosis 
Clinical sample, recruited from the  
Kermanshah MS Society 
Fledderus et al., 2010 Netherlands 93 49 (24-71) 18.3 Individuals with mild to moderate distress 
Clinical sample, recruited from mental health 
institutions 
Fledderus et al., 2012 Netherlands  376 42 (18-73) 30 
Individuals with mild to moderate depressive 
symptomology 
Non-clinical sample, recruited from the 
general population  
Grégoire et al., 2018 Canada  144 31.7 (SD: 9.22) 26.4 
Undergraduate and postgraduate university 
students 
Non-clinical sample, recruited from four 
participating universities  
Lundgren et al., 2008  India  18 23.5 (18-55) 66 Individuals with an epilepsy diagnosis with 
drug refractory seizures 
Clinical sample, recruited from clinics  
Majumdar et al., 2018 England 53 62.7 (SD:13.9) 32 Individuals who had experienced a stroke, no 
degenerative, ABI or cognitive difficulties 
Clinical sample, recruited from stroke clinics 
Pots et al., 2016 Netherlands  236 46.8 (SD:12.06) 24 
Individuals with mild to moderate depressive 
symptomology 
Non-clinical sample, recruited from the 
general population  
Ransanen et al., 2016 Finland 68 24.3 (19-32) 14.7 University students with self-reported distress 
(stress, low mood and/or anxiety) 
Non-clinical sample, recruited from  
participating university 
Thorsell et al., 2011 Sweden 90 46 (12.3) 35.6 Individuals experiencing chronic pain Clinical sample, Specialty Pain Clinic  
Trompetter  
et al., 2014 



























Attrition Rates % Findings  
(Reported Effect 











1) Acceptance and Commitment group 
(ACT; n=20); content n/s;  
Delivered by: the author (1 group).  
 
2) Narcotics Anonymous group (NA; 
n=20). Contentn/s  











weekly x 1.5 
hours 
 





























ACT group showed 
significantly greater 
gains in well-being 
relative 
to the NA and 
control 




Bayati et al., 
2017 
Group ACT group for living with pain (n=15) 
based on unpublished manual.  
Sessions covering: limits of control; 
values; cognitive defusion; committed 
action; review; moving forward. 
 






ACT group= 8 







8 weeks (T1) 




From T0-T1 ACT 
group showed 
greater gains in 
wellbeing relative 






Fledderus et al ., 
2010 
 
Group ACT group “living to the full”  (n=49) 
based on manual.  
Sessions covering: acceptance; 
cognitive defusion; contact with present 
moment; self-as-context; values; 
mindfulness.  
 
Delivered by: teams of 2 licensed 

































gains in well-being 
(MHC-SF; T0-T1 d 
= 0.56; T1-T2 d = 
0.85 






















Attrition Rates % Findings  
(Reported Effect 












ACT groups “KORSA” based on manual 
(n=72). Sessions covering: values; 
committed action; acceptance; cognitive 
defusion; mediation; mindfulness. Mediation 
and observation grid home works.  
 
Delivered by: two doctoral-level 







ACT group= 4 
weekly x 2.5 hours 
 
WBMMS 
Completed at:  
Baseline (T0) 

















From T0-T1  
those receiving ACT 
showed significantly 
greater gains in well-
being  
(WBMMS; d = 0.61) 




Group ACT groups “ACTivate Your Life after 
Stroke” (n=26)  based on manual.  
Sessions covering:  didactic presentations 
including ACT activities.  
 
Delivered by: clinical and assistant 







weekly x 2 hour 
sessions 
WEMWBS 
Completed at:  
Baseline(T0)  
4 weeks (T1)  












From T0-T1  
those receiving ACT 
showed significantly 
greater gains in well-
being  
(WEMWBS; Ƞ2 = 
0.07) when compared 
to TAU. At T2 FUP 



















1) ACT group/ individual sessions for 
epilepsy (n=10) based on published 
manual, ‘adapted for Indian context’. 
Sessions covering: values; self-as-
context; defusion; acceptance; 
committed action. ABC home works. 
        Delivered by: two clinical             
psychologists 
 
2) Yoga group/ individual sessions for 
epilepsy (n=8) based on a manual. 
Sessions covering: stimulating activity 
in directions the participants considered 
meaningful and using yoga technique to 
decrease the risk of seizures.  
       Delivered by: yoga teacher at the clinic 
N/A 
 




1 x initial 
individual session 
(1.5 hours) 2 x 
group sessions (3 
hours)1 x final 
individual session 
(1.5 hours) . 
 
 2 x booster 
sessions at 6 and 12 





5 weeks (T1) 
 26 weeks 
(T2) 























































N/A From T0-T4 (effect 
sizes were calculated 
using the 
mean of all post 
measure points) those 
receiving Yoga group 
showed significantly 
greater gains in well-
being  
(WEMWBS; d = 
0.58) compared to 
ACT group 
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1) ACT online intervention (n=82) “Living 
to the full” based on published self-help 
intervention. Nine online modules 
covering: cognitive defusion; 
acceptance; mindfulness; self-as-
context; values; committed action. 
Mindfulness home works.    
 
2) Expressive writing (EW) intervention 
(n=67) based on published text. 9 online 
modules covering: EW regarding 
negative experiences; reflection 
emotional regulation, reappraisal of 
emotions); EW of positive experiences. 
EW home works.  
 
Both delivered by: 5 psychology students 








ACT and EW 
group= 9 modules 
to be completed 











12 weeks (T1) 
26 weeks (T2) 
 
ACT and EW 


























From T0-T1 and at 




gains in wellbeing 
when compared to 
EW and WLC 
groups. At T1 
(MHC-SF; ACT vs 
EW d=0.35, ACT 
vs WLC d=0.39). 
 









ACT online intervention (n=33) “iACT”. 
based on a published protocol and adapted 
for students based on published self-help 
intervention. Five modules covering: values; 
taking action; being present; observer self; 
awareness; acceptance. Home works (e.g. 
practicing skills and wellbeing tasks).   
 
Delivered by: 22 ACT-trained psychology 
students (third year and above) did 
individual sessions and provided 














completed over 7 
weeks:  
1 x initial 
individual session  
Completed 5 online 
modules  





















































 From T0-T1  
those receiving ACT 
showed significantly 
greater gains in well-
being  
(MHC-SF; d = 0.46) 
when compared to 
WLC 
At T2 FUP of those 
in the ACT condition, 
































Attrition Rates % Findings  
(Reported Effect 













1) ACT online intervention (n=82) “Living 
with pain” based on published self-help 
programs. Nine online modules 
covering: cognitive defusion; 
acceptance; mindfulness; self-as-
context; values; committed action. 
Mindfulness home works.    
 
2) Expressive writing (EW) intervention 
(n=79) based on published text. 9 online 
modules covering: psycho-education 
about emotions and emotion regulation 
related to the pain experiences, followed 
by EW.  
 
Both delivered by: 5 psychology students 








ACT and EW 
group= 9 modules 












12 weeks (T1) 

























T0-T2 those receiving 
ACT showed no 
significantly greater 
gains in well-being  
in comparison to 
WLC or EW.  
 





1) ACT extensive support intervention: 
participants received published self-
help book “living to the full” with 
extensive email support (n=125). Nine 
online modules covering 6 core ACT 
processes. Mindfulness home works  
 
2) ACT minimal support intervention: 
participants received published self-
help book “living to the full” with 
minimal email support (n=125). Nine 
online modules covering core ACT 
processes. Mindfulness home works  
 
Both delivered by: 5 psychology students 








groups= 9 modules 






















































 From T0-T1  
those receiving ACT  
extensive and 
minimal support  
showed significantly 
greater gains in well-
being compared to 
WLC (ACT-E; 
d=0.51-0.62 ACT-M; 
d = 0.56-0.79). No 
significant differences 
in wellbeing between 
the two ACT 
conditions.  
 
At T2 FUP ACT 
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1) ACT intervention: participants 
received published self-help book 
“living beyond your pain” (n=61) 
covering ACT processes: values; 
committed action; mindfulness; 
cognitive defusion; acceptance; 
avoidance 
 
2) Applied relaxation: participants 
received self-help manual (N=54) 
covering progressive, cued, 
differential and rapid relaxation 
 





ACT and AR 
groups= 8 
sessions over 7 
weeks  
 





6 x telephone 
sessions  
 









7 weeks (T1) 
 26 weeks (T2) 
































T2 FUP and at 
T3 FUP. 
Those in the 
AR 









Wellbeing measures: MHC-SF: Mental Health Continuum- Short Form, PWB: Ryffs Psychological Wellbeing Scale, SWLS: Satisfaction with Life Scale, WBMMS: Well-Being 
Manifestations Measure Scale, WEMWBS: Warwick and Edinburgh Mental Well-being Scale. Other Measures: AAQ-II: Acceptance and Action Questionnaire, AES: Academic 
Engagement Scale: AHS: Adult hope scale: BDI-II: Beck Depression Inventory CED-S: Center for Epidemiologic Studies Depression Scale: CPAQ: Chronic Pain Acceptance 
Questionnaire, CIS: Checklist Individual Strength, DASS-21: Depression, Anxiety, Stress Scale, ELS: Engaged Living Scale, EQ5D5L: EuroQol five-dimensional questionnaire, 
FFMQ/-SF: Five Facet Mindfulness Questionnaire/short-form, HADS, Hospital Anxiety and Depression Scale, MEAQ: Multidimensional Experiential Avoidance Questionnaire, 
MINI: Mini International Neuropsychiatric Interview, MPI: Multidimensional Pain Inventory, OLQ-13: Orientation to Life Questionnaire; OMPQ: Orebro Musculoskeletal Pain 
Questionnaire, PCS: Pain Catastrophizing Scale, PDI: ain Disability Index, PIPS: Psychological Inflexibility in Pain Scale, PHQ-9: Patient Health Questionnaire-9, PSS-10: 
Perceived Stress Scale, SDS: Sheehan Disability Scale , WHO-QOL-BREF: World Health Organization Quality of Life Instrument- Short Version.  
Effect sizes: d= Cohen’s d. (d= 0.2 is considered as a small effect; d=0.5 as medium; and d=0.8 as large) (Cohen, 1992).Ƞ = eta squared(Ƞ2= 0.01 is considered a small effect, Ƞ2= 0.06 is 













The aim of the current review was to synthesise and critically appraise the research 
findings of randomised controlled trials (RCTs) investigating ACT interventions that assessed 
subjective well-being (SWB) as an outcome. The review sought to evaluate the 
methodological rigor of these RCTs, the ranges of assessment measures used, and the 
reported levels of efficacy of ACT in bringing about changes in SWB. Eleven studies were 
identified as meeting criteria for inclusion.  
Methodological quality and rigor 
 
 The Cochrane Risk of Bias Tool was utilised to asses  risk of bias (Higgins & Green, 
2011). The methodological quality of the included studies was variable. In one domain 
‘blinding of participants/ personnel’, a high risk of performance bias was found across all the 
included studies. This represents an important limiation of therapy research in general, and is 
not specific to ACT (Munder & Barth, 2018). Three studies (Pots et al., 2016; Ransanen et 
al., 2016; & Trompetter et al, 2014) demonstrated comparatively low levels of risk of bias 
overall. These studies clearly documented procedures for sequence generation, handling 
incomplete data, and provided detailed descriptions of interventions. In contrast, two studies 
were deemed ‘low risk’ in less than two domains, with the majority deemed ‘high’ or 
‘unclear risk’ (Azhosh et al., 2016; Bayati et al., 2017). These studies provided insufficient 
information on key aspects of the research designs and interventions. Across all studies: 53% 
of domains were deemed ‘low risk, 28% ‘unclear risk’, and 19% were deemed ‘high risk’ of 
bias. This review highlights the need for future researchers to improve clarity and 
transparency when reporting ACT trials. 
 Some important methodological difficulties highlighted in this review included 
inadequate reporting of allocation concealment, andinsufficient reporting/ handling of 
attrition data. Procedures to protect allocation sequence (randomisation) are essential in RCTs 
(i.e. using external agencies to allocate participants), and such procedures need to be 
documented to ensure selection bias is not introduce . With regards to attrition, two studies 
provided insufficient information relating to drop-outs or handling of missing data and a 
further two studies used simple imputation methods (la t observation carried forward) which 
can lead to bias or misleading results. Future research should endeavour to publish and 
reference trial protocols as this was undertaken in only a minority of the included studies. 
This would facilitate a more detailed assessment of internal validity.  
 In order to overcome some of the inherent bias introduced in therapeutic research, in 
which neither participants nor personnel can remain bli ded, an additional domain 
‘deviations from intended interventions’ was considered (Higgins et al., 2016). This domain 
allowed the authors of this review to assess treatmn  implementation and integrity (i.e. 
therapist/ participant adherence, training etc.) and treatment ‘dosage’. Most of the studies 
were deemed ‘low risk’ of this type of performance bias. Where risk was deemed ‘unclear’, 
this judgement arose due to a failure to report participants’ adherence to the interventions. In 
two studies no details of therapist training, treatment fidelity measures and/or participant 
adherence were provided (Azhosh et al., 2016; Bayati et al., 2017). Of those studies deemed 
‘low risk’, the majority were manualised, and included details of therapist training and 
reported high levels of participant adherence (balanced across active groups).  
 Additional methodological issues highlighted in the included studies included small 
sample bias, and a lack of active comparators, resulting in a lack of control for non-specific 
therapeutic factors (n=6). Such limitations echo findings of previous systematic reviews of 










Whilst this review sought to appraise and synthesise published RCTs (often 
considered the ‘gold standard’ in evidence-based research), it must be acknowledged that this 
is likely to skew conclusions with regards to ‘publication bias’. With regards to this type of 
selection bias, we cannot determine whether or not there are additional ACT, RCTs that 
included SWB outcomes, but may not have been published due to non-significant results. 
Hence the importance of researchers of publishing pre-trial protocols.   
  
Range of wellbeing measures utilised in included studies 
 
 A total of five different standardised measures of SWB were used in the included 11 
studies. The most commonly used measure was the MHC-SF (Keyes, 2002) which was 
utilised in five studies, followed by the PWB scale used in two studies, and the SWLS 
(Diener et al., 1985) used in two studies. In a finl two studies the WBMMS (Massé et al., 
1998) and WEMWBS (Ruth at el., 2007) were utilised. This range of measures reflects a 
divergence in how SWB is conceptualised and operation lised within the wider research 
community (Cooke et al., 2016; Forgeard, Jayawickreme, Kern, & Seligman, 2011) 
Whilst there was no general consensus as to how wellbeing should be measured in the 
included studies, the MHC-SF featured most prominently. In addition to providing a total 
score, this measure allows individuals to be classed as “flourishing” (highest level of 
wellbeing), “languishing” (lowest level of wellbeing) or “moderately mentally healthy” 
(neither “flourishing” nor “languishing”) based on scores on individual indices of both 
hedonic and eudemonic aspects of the SWB construct (Keyes, 2002). This measure has 
previously demonstrated good internal reliability (α= 0.89) and test-retest reliability (0.65; 
Lamers, Westerhof, Bohlmeijer, Klooster & Keyes 2011). 
Consistent with previous meta-analysis and reviews of ACT the majority of the 
research focused on symptom outcomes as a primary measure with only five studies 
specifying SWB outcomes as a primary outcome. As highlighted by previous authors, this 
represents a fundamental shortcoming in the evidence-base - symptom reduction is not the 
primary aim of ACT interventions. Notably, the majority of the studies in this review were 
published within the last two years, and were all group-based or guided self-help. This is 
likely to reflect the increasing use of SWB measure, and a rise in these formats for therapy 
that serve to increase access to therapies (Gellatly et al., 2007). Moving forward, greater 
emphasis should be placed on evaluating the impact of ACT on SWB as a primary outcome.  
 
 
Reported levels of efficacy for wellbeing outcomes  
 
   
Meta-analyses were conducted separately for each SWB measure post-treatment 
(MHC-SF score, PWB score, SWLS score, WBMMS score and WEMWBS score) using 
standardised mean deviations. Results indicated that all but one study (Majumdar & Morris, 
2018) showed significant results in favour of ACT (when compared to controls), with the 
majority of studies demonstrating moderate effect sizes. As previously highlighted, in those 
studies utilising PWB to measure SWB (Azkhosh et al, 2016; Bayati et al., 2017), very large 
effect sizes favouring ACT were evident. It is important to note that there was a high level of 
heterogeneity between these two studies, and that sample sizes were small. These studies also 
demonstrated had the least numbers of ‘low risk’ ratings in the Risk of Bias analyses, 












The results of this current meta-analysis can be compared with a recently completed 
complementary meta-analysis that explored ACTs role in wellbeing promotion of 
undergraduate students specifically (Howell & Passmore, 2019). In contrast to the current 
review, this research focused solely on non-clinical samples, covering only ACT 
interventions targeted at university students. The included studies were predominately web-
based studies (including non-guided formats). Of the five studies included in this review, 
ACT interventions were found to have small, positive effect on university students’ wellbeing 
(pooled effect size= d=0.29). 
 
Strengths and limitations of the current review 
 
   
The scope of the current review included a wide variety of populations, and ACT 
formats (i.e. group, mixed, guided self-help; online or books) and outcome measures of SWB. 
As ACT is a transdiagnostic intervention, and is increasingly delivered in diverse formats this 
can be viewed as strength of the current review. Furthermore, the focus of this review on 
SWB as an outcome, is model-consistent (i.e. an outcome that ACT purports to target). The 
current study included a meta-analysis of all 11 studies; this was a series of meta-analyses for 
each post-treatment measure of SWB. It must be highlighted that a wide variety of controls 
were included in this analysis (e.g. wait list contr ls, treatment as usual, and active controls 
such as yoga). It is also important to consider the high number of non-active controls (9 out 
of the 11 studies) which are likely to maximise the magnitude of the results, and effect sizes 
in the included meta-analysis. Furthermore, comparisons with non-active controls do not 
account for non-specific factors. As stated previously, the included analysis did not account 
for ‘group effects’, as the data was not available to be incorporated into our analysis.  
The current review used a broad search strategy, and was inclusive of all studies 
incorporating standardized measures of SWB as listed, or against the criteria specified in a 
recent comprehensive review of SWB measures (Cooke et al., 2016). For the purpose of this 
review quality of life (a conceptually distinct term to SWB) was purposely excluded from 
search terms (Cooke et al., 2016; Pinto, Fumincelli, Mazzo,Caldeira, & Martins, 2017). 
Subjective wellbeing is often erroneously confused with Quality of Life. Research and 
theory has sought to highlight the distinctiveness of these concepts. Pinto et al. (2017) noted 
that in terms of Quality of Life: ‘the majority of authors define the concept as the individual’s 
perception of their personal situation in their own life in the physical, social, mental and 
spiritual dimensions’ (P7). Subjective well-being on the other hand is purported to consist of 
three interrelated components: life satisfaction, pleasant affect, and unpleasant affect. Affect 
refers to pleasant and unpleasant moods and emotions, whereas life satisfaction refers to a 
cognitive sense of satisfaction with life’ (Diener & Suh, 1997, p. 200). To capture the overlap 
but distinctiveness of these concepts, Dodge et al. (2002) proposed that quality of life can be 
considered a dimension of the broader concept of wellbeing. 
 
  
Recommendations for Future Research 
 
There is an evident need for researchers within the ACT community to use more 
appropriate model-consistent outcomes such as SWB in future RCTs. Increasing the use of 











focused on specific formats of ACT, or measures). Given the vast number of available, 
standardised measures of SWB is it suggested that authors be explicit about their choice of 
measure, and underlying conceptualisation of SWB. In the current review, the most 
commonly utilised measure was the Mental Health Continuum-Short Form (MHC-SF). As 
stated, this measure captures both hedonic and eudemonic aspects of the SWB, and has 
demonstrated good internal reliability and test-retest reliability. The use of this existing 
measure in future RCTs may be allow for consistency i  how SWB is measured in ACT, 
thereby progressing the field and moving away from symptom-focused outcomes. Moving 
forward, ACT theorists and researchers could play an important role in helping to refine and 
finesse how SWB is conceptualized and measured informed by the ACT model.  
 The inclusion of active controls in these designs would further strengthen the 
evidence base of ACT, and control for non-specific therapeutic factors. In this review half of 
the studies included had a relatively short FUP, or did not include one. In future, studies with 
longer FUP are necessary to explore the long-term effects of ACT interventions on SWB. 
Furthermore, the reporting of reasons for attrition during future RCTs, would allow for a 
formal meta-analysis of attrition going forward, which may particularly informative to the 
research community as the literature base grows.  
 
The findings of this review also highlight the need for careful consideration, 
transparency and clarity when designing and reporting trials (e.g. procedures for allocation 
concealment, reporting and handling of missing data). In this review, the addition of 
“deviations from intended interventions” a new RoB category (Higgins et al., 2016) allowed 
the authors to consider bias in relation to therapy integrity and adherence. It is suggested that 
future reviewers, and trial investigators utilise these criteria when conducting therapeutic 
research. There is scope for future research to explore the relationship between SWB and 
symptom/illness outcomes, given that the majority of published studies have included SWB 
measures alongside these measures (i.e. depression). Further studies may also wish to explore 
the active components of ACT interventions (i.e. processes such as cognitive defusion) in 
improving SWB. 
The findings of this review and aforementioned litera ure indicate that there is an 
increasing recognition that SWB may be improved in both clinical and non-clinical 
populations using ACT interventions. Whilst much of the research to date in non-clinical 
populations has been conducted with students, these interventions may also be applied in a 
broader range of contexts (e.g. in workplaces, elite evel sporting contexts, prisons, 
community groups etc.) and with a broader range of populations (e.g. older adults) in order to 
promote and enhance positive mental health. Furthermore, there is now an increasing 
recognition that ACT may help to elevate the SWB of vulnerable groups (e.g. refuges and 
those experiencing humanitarian crisis). Finally, the inclusion of booster sessions may help to 
improve longer-term outcomes and maintain positive outcomes in both research trials and 







The current systematic review sought to synthesise and critically appraise the research 
findings of RCTs of ACT interventions that have assessed SWB. Whilst caution must be 
exercised when generalising the findings of this review, the included studies indicate that 











clinical populations. Future RCTs that include standardised measures of SWB are necessary 
to facilitate further meta-analysis. The methodological limitations highlighted in this review 
indicate the need for further high-quality studies, with larger sample sizes and active 
comparators. It is hoped that these recommendations will facilitate an improved 
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• This review investigated the range of subjective wellbeing measures used in ACT 
research;  
• the effectiveness of ACT in enhancing wellbeing, and methodological rigour of these 
studies.  
• 11 randomised controlled trials were included comparing ACT interventions with 
control groups. 
• ACT interventions enhance subjective well-being in clinical and non-clinical samples.  
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